Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Gross Margin (2016 - 2023)

Historic Gross Margin for Perspective Therapeutics (CATX) over the last 14 years, with Q4 2023 value amounting to 0.8%.

  • Perspective Therapeutics' Gross Margin changed N/A to 0.8% in Q4 2023 from the same period last year, while for Dec 2023 it was 100.0%, marking a year-over-year increase of 610100.0%. This contributed to the annual value of 100.0% for FY2023, which is N/A changed from last year.
  • Perspective Therapeutics' Gross Margin amounted to 0.8% in Q4 2023.
  • In the past 5 years, Perspective Therapeutics' Gross Margin registered a high of 59.24% during Q1 2020, and its lowest value of 0.8% during Q4 2023.
  • In the last 5 years, Perspective Therapeutics' Gross Margin had a median value of 45.69% in 2019 and averaged 40.49%.
  • Per our database at Business Quant, Perspective Therapeutics' Gross Margin skyrocketed by 198400bps in 2019 and then tumbled by -259100bps in 2023.
  • Perspective Therapeutics' Gross Margin (Quarter) stood at 50.36% in 2019, then dropped by -2bps to 49.47% in 2020, then decreased by -12bps to 43.32% in 2021, then plummeted by -44bps to 24.11% in 2022, then plummeted by -97bps to 0.8% in 2023.
  • Its Gross Margin was 0.8% in Q4 2023, compared to 33.78% in Q3 2023 and 11.88% in Q2 2023.